# DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

> **NCT06009835** · — · UNKNOWN · sponsor: **Tianjin Medical University Second Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Solid Tumor
- Individuation

## Interventions

- **OTHER:** Recommended treatment plan

## Key facts

- **NCT ID:** NCT06009835
- **Lead sponsor:** Tianjin Medical University Second Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-07
- **Primary completion:** 2024-08-07
- **Final completion:** 2024-09-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06009835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06009835, "DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06009835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*